This page lists all pharmaceutical reports related to the field of Neurodegenerative & Neuroelectrophysiological Disorders. The reports include market research reports and pipeline analyses.
Displaying 51 - 100 of 139 results
- Licensing Strategies - Current Pharmaceutical Licensing Trends
- Coxibs - Past Problems and Future Potential
- Tysabri - Can Efficacy of VLA-4 Mechanism Overcome Safety Concerns?
- Commercial Insight: Parkinson's Disease - Increased Focus on Earlier Treatment and Managing Levodopa
- Commercial Perspectives: Multiple Sclerosis - How to Find Opportunities in an Unremitting Market
- Alzheimer's Disease - Diagnosis, Disease Modification and Prevention Key to Growing Market
- The Outlook for Niche CNS Disorders: Commercial opportunities in developing markets
- Commercial Opportunities from an Aging Population: Epidemiology, market and pipeline analysis across seven major indications
- Innovations in CNS: Novel therapeutics and future R&D strategies
- Gene Expression Profiling Markets
- UpdatesPlus-Nicotinic Receptors (January 2008)
- The Pharmaceutical Company Outlook to 2012: Strategic Analysis of Sales Outlook for Big Pharma
- Pipeline Insight: Orphan Diseases in CNS - Amyotrophic Lateral Sclerosis
- Parkinson's Disease - Evidence of neuroprotection essential to progress treatment dynamics
- How to Conduct Clinical Trials in China
- Alzheimers Disease Market analysis and forecasts, 2007-2022
- Nanotechnology: Revolutionizing R&D to develop smarter therapeutics and diagnostics
- UpdatesPlus-Nicotinic Receptors (February 2008)
- Parkinson's Disease Market analysis and forecasts
- Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development
- Neuronal Nicotinic Receptors: UpdatesPlus March 2008
- Biogenerics - The World Market: Biosimilars and Biologics at a Crossroads
- Pipeline and Commercial Insight: Alzheimer's Disease
- The Fastest Growing Biotechnology Companies: Growth strategies, comparative analyses and company profiles
- The Future of Targeted Therapeutics: Key technologies, new therapy area applications and leading players
- CNS Market Overview - neurology, pain and psychiatry
- Neuronal Nicotinic Receptors - April 2008
- Outsourcing in Drug Discovery
- Pipeline Insight: Acute Stroke: Commercial risk offsets high unmet need
- Neuronal Nicotinic Receptors - June 2008
- Monoclonal Antibodies Report: 2008 Update
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Neuronal Nicotinic Receptors - July 2008
- The World Alzheimer's Disease Market (Incidence, Treatments, Key Companies, Pipeline and Trends)
- Therapeutic Monoclonal Antibodies Report 2008-2023
- Diagnostics in Neurology - Predictive biomarkers expand drug revenues
- Neuronal Nicotinic Receptors - August 2008
- Neuronal Nicotinic Receptors - September 2008
- The CNS Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Stakeholder Opinions: Vaccine adjuvants
- Ion Channel Trends 2008
- Kinase Screening & Profiling Trends 2008
- GPCR Screening & Profiling Trends 2008
- Neuronal Nicotinic Receptors - October 2008
- The CNS Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- The Future of RNAi Therapeutics: Drug Pipelines and Prospects
- Neuronal Nicotinic Receptors - November 2008
- Two pharmaceutical reports for the price of one - End of year offer
- Medical Imaging Markets